Search Results 81-90 of 16759 for CLL

  1. A Study to Evaluate the Safety and Tolerability of KTE-X19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Mayo Clinic

    The primary purpose of this study is to evaluate the safety and tolderability of KTE-X19 in adults with relapsed/refractory chronic lymphocytic leukemia (r/r ...

  2. A Study to Evaluate the Effectiveness and Safety of Panzyga in Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    ... Chronic Lymphocytic Leukemia (CLL) patients with secondary immunodeficiency (SID) undergoing CLL antineoplastic therapy. Participation eligibility.

  3. Hematology - Clinical trials

    ... chronic lymphocytic leukemia (CLL). MC230818 Understanding the mechanisms of clonal and non-clonal cytopenia following CAR-T therapy (MC230818). Mankato ...

  4. A Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate oral LOXO-305 in patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin ...

  5. Green Tea Archives - Mayo Clinic News Network

    as CLL or Chronic Lymphocytic Leukemia. Mayo Clinic Dr. Tait Shanafelt talks about the latest research. To listen, click the link below. Green Tea Toxicity.

  6. Household Controls for Clinical and Epidemiological Studies in Lymphoma and Chronic Lymphocytic Leukemia

    ... Chronic Lymphocytic Leukemia (CLL) with controls from a normal household and age-matched population. Participation eligibility. Participant eligibility ...

  7. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...

  8. Clinical trials - Oncology (Medical)

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  9. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    Giving ibrutinib and obinutuzumab with venetoclax may work better at treating chronic lymphocytic leukemia. Participation eligibility. Participant eligibility ...

  10. Mayo Clinic Biobank - Cancer

    Chronic lymphocytic leukemia. Asish K. Ghosh, Ph.D., is researching the relationship of microvesicles to chronic lymphocytic leukemia (CLL) development.